Oxysterols and NMDAR Function
氧甾醇和 NMDAR 功能
基本信息
- 批准号:8693215
- 负责人:
- 金额:$ 39.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-21 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:25-hydroxycholesterolAccountingAdultAffectBehaviorBehavioralBinding SitesBioavailableBiologicalBiologyBrainCYP46A1 geneCell membraneCellsCellular biologyChemicalsChemistryCholesterolClinicalCognitionCognitiveCollaborationsComplementDataDiseaseEnzymesFosteringHeart DiseasesHippocampus (Brain)Histocompatibility TestingHydroxycholesterolsImageKetamineKineticsLaboratoriesLeadLearningLeftLifeLipidsLung diseasesMeasurementMeasuresMediatingMental DepressionMental disordersMusN-Methyl-D-Aspartate ReceptorsNervous System PhysiologyNeuromodulatorNeuronsPharmacotherapyPhysiologicalPhysiologyPositioning AttributePropertyRefuse DisposalRodentRoleSchizophreniaSignal TransductionSiteSliceSterolsStimulusStructureSynapsesSynaptic TransmissionSynaptic plasticitySynthesis ChemistrySystemTestingTherapeuticTissuesWild Type MouseWorkanalogautocrinecholesterol 24-hydroxylasedrug developmentimprovedinnovationinsightinterdisciplinary collaborationinterestknockout animalmedical schoolsneuropsychiatryneuroregulationneurosteroidsnoveloxidationparacrinepostsynapticprototypepublic health relevancereceptorreceptor bindingreceptor functiontransmission processtreatment strategywasting
项目摘要
DESCRIPTION (provided by applicant): Current psychiatric pharmacotherapy options leave much to be desired, and manipulation of N-methyl-D-aspartate receptors (NMDARs) by positive and negative regulators has therapeutic benefit in major psychiatric disorders including schizophrenia and depression. We propose to capitalize on our recent discovery of a novel, very potent, and potentially endogenous positive modulator of NMDARs. The prototype is the major cholesterol metabolite in brain, 24S-hydroxycholesterol (24OH). Oxysterols like 24OH are cellular lipids generated from oxidation of cholesterol. Prevailing views suggest 24OH is synthesized as a convenient waste disposal vehicle for the neuronal pool of cholesterol that turns over in brain, but we have discovered that 24OH modulates NMDAR function at concentrations well below those measured in brain. We will leverage innovative chemical biology and physiological approaches toward understanding the mechanisms of 24OH. Our preliminary data suggest that 24OH and a synthetic analogue, Org-1, have unusual potentiating actions at NMDARs that are antagonized by another cholesterol metabolite, 25-hydroxycholesterol. We hypothesize that 24OH has direct effects on NMDAR channel gating through a novel receptor binding site. To understand mechanisms of oxysterol neuromodulation, we exploit a longstanding interdisciplinary collaboration with a synthetic chemistry laboratory, directed by Douglas Covey. We propose to use novel chemical tagging strategies to create analogues for cell biological and physiological studies. These approaches will yield insight into subcellular domains of exogenous oxysterol actions and insight into the peculiar kinetics of oxysterol action. We will also investigate the effects of 24OH and Org-1 on synaptic plasticity and behavior in wild type mice and in mice deficient in the enzyme that produces 24OH. Preliminary data suggest that 24OH and Org-1 enhance synaptic plasticity and cognition. This work will be complemented by measurements of endogenous 24OH and Org-1 levels under varied experimental conditions by collaborators at Weill Cornell Medical College. We have a strong interdisciplinary track record that will foster rapid progress. Upon completion of these studies, we expect to have elucidated mechanisms and effects of a novel neuromodulator with broad importance.
描述(由申请人提供):当前的精神病药物治疗方案还有很多不足之处,并且通过正和负调节剂对N-甲基-D-天冬氨酸受体(NMDAR)操纵,对包括精神分裂症和抑郁症在内的主要精神病患者具有治疗益处。我们建议利用我们最近发现的NMDAR的新颖,非常有效且潜在的内源性阳性调节剂。该原型是大脑中主要的胆固醇代谢物,24S-羟基胆固醇(24OH)。诸如24OH之类的氧化酚是由胆固醇氧化产生的细胞脂质。流行视图表明24OH被合成为胆固醇神经元池的方便废物处理车,但我们发现24OH在浓度低于大脑中的浓度下调节NMDAR功能。我们将利用创新的化学生物学和生理方法来理解24OH的机制。我们的初步数据表明,24OH和一个合成类似物ORG-1在NMDAR中具有异常增强的作用,而NMDAR与另一种胆固醇代谢物(25-羟基胆固醇)对抗。我们假设24OH通过新型受体结合位点对NMDAR通道门控具有直接影响。为了了解氧蛋白酶神经调节的机制,我们利用了由道格拉斯·科维(Douglas Covey)执导的合成化学实验室的长期跨学科合作。我们建议使用新型的化学标记策略来为细胞生物学和生理研究创建类似物。这些方法将洞悉外源氧蛋白酶作用的亚细胞结构,并洞悉氧蛋白酶作用的特殊动力学。我们还将研究24OH和ORG-1对野生型小鼠突触可塑性和行为的影响,以及在产生24OH的酶中缺乏的小鼠中的影响。初步数据表明24OH和ORG-1增强了突触可塑性和认知。 Weill Cornell医学院的合作者在不同的实验条件下,内源性24OH和ORG-1水平的测量将得到补充。我们拥有强大的跨学科往绩,这将促进快速进步。这些研究完成后,我们期望具有广泛重要性的新型神经调节剂的机制和影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN J MENNERICK其他文献
STEVEN J MENNERICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN J MENNERICK', 18)}}的其他基金
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUS
海马和丘脑中的 GABAA 受体群
- 批准号:
10220479 - 财政年份:2021
- 资助金额:
$ 39.78万 - 项目类别:
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUS
海马和丘脑中的 GABAA 受体群
- 批准号:
10378156 - 财政年份:2021
- 资助金额:
$ 39.78万 - 项目类别:
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUS
海马和丘脑中的 GABAA 受体群
- 批准号:
10582653 - 财政年份:2021
- 资助金额:
$ 39.78万 - 项目类别:
Neuroactive steroids as novel psychiatric treatments: mechanistic studies
神经活性类固醇作为新型精神病治疗:机制研究
- 批准号:
10198240 - 财政年份:2021
- 资助金额:
$ 39.78万 - 项目类别:
Neuroactive steroids as novel psychiatric treatments: mechanistic studies
神经活性类固醇作为新型精神病治疗:机制研究
- 批准号:
10662398 - 财政年份:2021
- 资助金额:
$ 39.78万 - 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 39.78万 - 项目类别:
A rigorous test of dual process model predictions for problematic alcohol involvement
对有问题的酒精参与的双过程模型预测的严格测试
- 批准号:
10679252 - 财政年份:2023
- 资助金额:
$ 39.78万 - 项目类别:
Feasibility Trial of a Novel Integrated Mindfulness and Acupuncture Program to Improve Outcomes after Spine Surgery (I-MASS)
旨在改善脊柱手术后效果的新型综合正念和针灸计划的可行性试验(I-MASS)
- 批准号:
10649741 - 财政年份:2023
- 资助金额:
$ 39.78万 - 项目类别:
The Illinois Precision Medicine Consortium (IPMC) All of Us Research Program Site
伊利诺伊州精准医学联盟 (IPMC) All of Us 研究计划网站
- 批准号:
10872859 - 财政年份:2023
- 资助金额:
$ 39.78万 - 项目类别:
NeuroMAP Phase II - Recruitment and Assessment Core
NeuroMAP 第二阶段 - 招募和评估核心
- 批准号:
10711136 - 财政年份:2023
- 资助金额:
$ 39.78万 - 项目类别: